Showing 91-100 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Improving the Uptake and Applicability of the Clinical and Economic Optimization Platform for Type 1 Diabetes Screening | Regents of the University of Colorado | R. Brett McQueen | Cures | 01-September-2024 to 31-August-2026 | $451.890,07 |
| Development of an injectable immunomodulatory niche technology for induction of immune tolerance to islet cell transplants | Stanford University | Eric Appel | Cures | 01-January-2025 to 31-December-2026 | $600.000,00 |
| Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D | Indiana Biosciences Research Institute | Michael Kalwat | Cures | 01-December-2024 to 30-November-2027 | $748.169,00 |
| GABP regulation of human beta cell proliferation | The University of Texas Health Science Center at Houston | Richard Cox | Cures | 01-September-2024 to 31-August-2026 | $200.000,00 |
| Integration of Slow-Release A1AT-loaded Nanoparticles for Enhanced Cell Therapy in Type 1 Diabetes | Beth Israel Deaconess Medical Center Inc | Giuseppe Pettinato | Cures | 01-October-2024 to 30-September-2025 | $200.000,00 |
| In vivo interactions and trafficking of islet antigen-specific human effector T cells and Tregs | University of Massachusetts Medical School | Michael Brehm | Cures | 01-November-2024 to 31-October-2027 | $825.000,00 |
| Relationship of Time-In-Range with microvascular complications in type 1 diabetes | Trustees of Indiana University | Viral Shah | Improving Lives | 01-February-2024 to 31-July-2025 | $71.123,95 |
| Identifying pharmaceuticals for enhancing metabolic maturity of stem cell derived islets | Regents of the University of Michigan | Lonnie Shea | Cures | 01-December-2024 to 30-November-2027 | $1.125.000,00 |
| Cognitive behavioral therapy to address anxiety in pre symptomatic type 1 diabetes | Regents of the University of Colorado | Holly O'Donnell | Cures | 01-July-2024 to 30-June-2027 | $600.000,00 |
| Long-read approaches to identify coding, non-coding, and structural variation that contributes to T1D risk | Benaroya Research Institute at Virginia Mason | Eddie James | Cures | 01-September-2024 to 28-February-2026 | $150.000,00 |